DIAGNOSTIC testing company R-Biopharm Rhône has reported a record year, thanks to strong organic growth in export markets.
The Glasgow company, a subsidiary of German diagnostics firm R-Biopharm AG, said its accounts for 2012 will show turnover growing 21.5% from £5.3 million to £6.4m.
That lift in income helped pre-tax profits surge more than 70% from £700,000 to almost £1.2m.
The business, based at the West of Scotland Science Park, had previously indicated it received a six-figure boost as a result of a large increase in lab testing following the horsemeat scare earlier this year and continuing strong demand for its products around the world is expected to see turnover top £7m during 2013.
Some 75% of the kits it makes are sold outside the UK mainly to food manufacturing businesses plus governments and private laboratories.
The kits are used to check for a range of naturally occurring poisons and ensure products being shipped for consumption are safe and meet regulatory requirements.
Simon Bevis, managing director, said: "We have been very encouraged by continuing successes in markets abroad. Sales in Asia are up by 50% to 60%, in Latin America we have seen a 50% increase and we have significant growth in Eastern Europe, too.
"It shows we have got our focus right. About three years ago, we decided to focus on emerging markets and we have managed to grow market share in those economies.
"Even subtracting the horsemeat blip, I would say we are growing faster this year than last year."
Mr Bevis said the company is also using its greater scale to get better terms from its suppliers and is considering bringing some outsourced functions back in-house.
A business development manager is starting with the company in the next few weeks and will be in charge of marketing a recently launched new system, called Immunoprep, for analysis of samples.
The automated process being used is expected to cut-out large amounts of manual work for laboratory staff and help to reduce costs in bigger laboratories by up to 30%.
Mr Bevis added: "We are continually seeking new opportunities and can look forward confidently to a prosperous future. We will continue to look to add staff if things keep progressing."
Mr Bevis said the company was working towards Investors in People gold status, having received the bronze award during 2012.
R-Biopharm AG has subsidiaries in the US, Italy, France, Latin America, Brazil, Spain, Australia and China.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article